Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions

  • F Pignatti, D Ashby, EP Brass, H-G Eichler, P Frey, HL Hillege, A Hori, B Levitan, L Liberti, RE Löfstedt, N McAuslane, A Micaleff, RA Noel, D Postmus, O Renn, BJ Sabourin, T Salmonson, S Walker
  • Clinical Pharmacology & Therapeutics, September 2015, Wiley
  • DOI: 10.1002/cpt.203

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1002/cpt.203

In partnership with: